MC1953A1 - Derives de la benzopyrane - Google Patents

Derives de la benzopyrane

Info

Publication number
MC1953A1
MC1953A1 MC881987A MC1987A MC1953A1 MC 1953 A1 MC1953 A1 MC 1953A1 MC 881987 A MC881987 A MC 881987A MC 1987 A MC1987 A MC 1987A MC 1953 A1 MC1953 A1 MC 1953A1
Authority
MC
Monaco
Prior art keywords
benzopyrane derivatives
benzopyrane
derivatives
Prior art date
Application number
MC881987A
Other languages
English (en)
French (fr)
Inventor
Richard Attwood Michael
Stephen Jones Philip
Redshaw Sally
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878715839A external-priority patent/GB8715839D0/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1953A1 publication Critical patent/MC1953A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
MC881987A 1987-07-06 1988-07-04 Derives de la benzopyrane MC1953A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878715839A GB8715839D0 (en) 1987-07-06 1987-07-06 Benzopyran derivatives
GB888810212A GB8810212D0 (en) 1987-07-06 1988-04-29 Benzopyran derivatives

Publications (1)

Publication Number Publication Date
MC1953A1 true MC1953A1 (fr) 1989-06-30

Family

ID=26292440

Family Applications (1)

Application Number Title Priority Date Filing Date
MC881987A MC1953A1 (fr) 1987-07-06 1988-07-04 Derives de la benzopyrane

Country Status (27)

Country Link
US (2) US4971982A (sh)
EP (1) EP0298452B1 (sh)
JP (1) JP2683581B2 (sh)
CN (1) CN1023404C (sh)
AR (1) AR245710A1 (sh)
AT (1) ATE91127T1 (sh)
AU (1) AU613646B2 (sh)
CA (1) CA1334094C (sh)
CZ (1) CZ285970B6 (sh)
DE (1) DE3882095D1 (sh)
DK (1) DK370988A (sh)
DZ (1) DZ1227A1 (sh)
ES (1) ES2056859T3 (sh)
FI (1) FI90079C (sh)
HU (2) HU202513B (sh)
IE (1) IE62258B1 (sh)
IL (1) IL86923A (sh)
IS (1) IS1596B (sh)
MC (1) MC1953A1 (sh)
MX (1) MX174083B (sh)
NO (1) NO170727C (sh)
NZ (1) NZ225163A (sh)
PH (1) PH27153A (sh)
PT (1) PT87913B (sh)
SK (1) SK279037B6 (sh)
SU (1) SU1757466A3 (sh)
YU (1) YU46918B (sh)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
US5284838A (en) * 1987-06-23 1994-02-08 Elf Sanofi Use of 2,2-dimethylchroman-3-ol derivatives in the treatment of asthma
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3918041A1 (de) * 1989-06-02 1990-12-06 Merck Patent Gmbh Chromanderivate
DE3922392A1 (de) * 1989-07-07 1991-01-17 Merck Patent Gmbh Chromanderivate
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
DE3926001A1 (de) * 1989-08-05 1991-02-07 Merck Patent Gmbh Chromanderivate
US5616610A (en) * 1989-12-22 1997-04-01 Astra Aktiebolag (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
CN1060467A (zh) 1990-09-25 1992-04-22 武田药品工业株式会社 1，3-苯并嗪衍生物、其生产方法和用途
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
DE4115465A1 (de) * 1991-05-11 1992-11-12 Beiersdorf Ag Neue in 4-stellung durch aryl oder n-heteroaryl substituierte 2h-benzo(b)pyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
FR2698873B1 (fr) * 1992-12-07 1995-02-24 Lipha Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
TW258735B (sh) * 1992-08-17 1995-10-01 Chugai Pharmaceutical Co Ltd
ES2064228B1 (es) * 1992-10-19 1995-09-01 Uriach & Cia Sa J Nuevas tetralonas con actividad farmacologica, composiciones que las contienen y procedimiento para su preparacion.
US5416097A (en) * 1993-05-19 1995-05-16 Berlex Laboratories, Inc. Potassium channel activators/openers
US5837702A (en) * 1993-10-07 1998-11-17 Bristol-Myers Squibb Co. 4-arylamino-benzopyran and related compounds
US5719155A (en) * 1993-11-10 1998-02-17 Japan Tobacco Inc. Chroman derivative and pharmaceutical use thereof
US5789419A (en) * 1994-06-09 1998-08-04 Ss Pharmaceutical Co., Ltd. 4-quinolinone derivative or salt thereof
US5470861A (en) * 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
US5629429A (en) * 1995-06-07 1997-05-13 Bristol-Myers Squibb Company Process for preparing 4-arylamino-benzopyran and related compounds
US5612323A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phosphinic ester substituted benzopyran derivatives
US5612370A (en) * 1995-06-07 1997-03-18 Bristol-Myers Squibb Company Phenylglycine and phenylalaninen amido benzopyran derivatives
US5869478A (en) * 1995-06-07 1999-02-09 Bristol-Myers Squibb Company Sulfonamido substituted benzopyran derivatives
KR100691511B1 (ko) * 1995-11-09 2007-04-19 다우 아그로사이언시즈 엘엘씨 크로만카복실레이트의제조방법
JP3885900B2 (ja) * 1996-03-22 2007-02-28 大日本インキ化学工業株式会社 ベンゾピラン誘導体及びそれを有効成分とする心臓疾患治療剤
WO1999001453A1 (en) * 1997-07-02 1999-01-14 F. Hoffmann-La Roche Ag A process for the manufacture of optically active chromanylpyridine derivatives
ATE274510T1 (de) 1998-06-19 2004-09-15 Chiron Corp Glycogen synthase kinase 3 inhibitoren
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
FI20010233A0 (fi) * 2001-02-08 2001-02-08 Orion Corp Menetelmä sydämen vajaatoiminnan hoitoon
AR035087A1 (es) * 2001-08-09 2004-04-14 Syngenta Participations Ag Piridil-alquinos y piridil-n-oxido-alquinos herbicidas activos, procedimiento para su preparacion, composicion herbicida y para inhibir el crecimiento de plantas, metodo para el control del crecimiento de plantas indeseables , y metodo para la inhibicion del crecimiento de plantas
AR040413A1 (es) * 2002-05-31 2005-04-06 Syngenta Participations Ag Heterociclilalquinos activos como herbicidas
AU2006284675A1 (en) * 2005-09-01 2007-03-08 Janssen Pharmaceutica N.V. Novel benzopyran derivatives as potassium channel openers
CA2620846A1 (en) * 2005-09-01 2007-03-08 Janssen Pharmaceutica N.V. Benzopyran and pyranopyridine derivatives as potassium channel openers
KR100799246B1 (ko) * 2006-12-13 2008-01-29 재단법인서울대학교산학협력재단 벤조피란을 중심구조로 갖는 화합물 및 이의 제조방법
CN103819395B (zh) * 2014-02-24 2016-05-25 蚌埠中实化学技术有限公司 一种制备2-碘-5-苯基吡啶的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1583811A (en) * 1977-05-09 1981-02-04 Laroche Navarron Sa Chromene derivatives
US4563468A (en) * 1979-09-13 1986-01-07 Burroughs Wellcome Co. Chemotherapeutic agents
HU184359B (en) * 1980-12-16 1984-08-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing substituted acyl-carbamides
US4443459A (en) * 1981-05-26 1984-04-17 Banyu Pharmaceutical Co., Ltd. α-Tocopheryl ester of 5-substituted picolinic acid and hypotensive composition containing it
GB2107706A (en) * 1981-09-25 1983-05-05 Beecham Group Plc Benzopyrans
DE3364734D1 (en) * 1982-10-19 1986-08-28 Beecham Group Plc Novel chromans and chromenes
DE3579390D1 (de) * 1984-06-22 1990-10-04 Beecham Group Plc Wirksame benzopyranverbindungen.
EP0218373B1 (en) * 1985-09-11 1990-03-07 Beecham Group Plc Chroman derivatives and analogues having antihypertensive activity
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
IL86798A (en) * 1987-06-23 1992-12-01 Sanofi Sa 2,2-dimethylchroman-3-ol derivatives, their preparation and pharmaceutical compositions containing them
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives

Also Published As

Publication number Publication date
HU202513B (en) 1991-03-28
DZ1227A1 (fr) 2004-09-13
DK370988D0 (da) 1988-07-04
CZ484188A3 (cs) 1999-10-13
ES2056859T3 (es) 1994-10-16
FI90079C (fi) 1993-12-27
IS1596B (is) 1996-04-12
JPS6438087A (en) 1989-02-08
DE3882095D1 (de) 1993-08-05
CA1334094C (en) 1995-01-24
FI883232A0 (fi) 1988-07-06
NO170727C (no) 1992-11-25
SK484188A3 (en) 1998-05-06
IS3369A7 (is) 1989-01-07
SU1757466A3 (ru) 1992-08-23
CZ285970B6 (cs) 1999-12-15
EP0298452A2 (de) 1989-01-11
EP0298452B1 (de) 1993-06-30
AU1855688A (en) 1989-01-12
YU130288A (en) 1990-06-30
NO883007L (no) 1989-01-09
CN1023404C (zh) 1994-01-05
JP2683581B2 (ja) 1997-12-03
CN1030582A (zh) 1989-01-25
IE882043L (en) 1989-01-06
IE62258B1 (en) 1995-01-11
IL86923A0 (en) 1988-11-30
US4971982A (en) 1990-11-20
PH27153A (en) 1993-04-02
AU613646B2 (en) 1991-08-08
YU46918B (sh) 1994-06-24
HU211870A9 (en) 1995-12-28
US5118694A (en) 1992-06-02
FI883232A (fi) 1989-01-07
FI90079B (fi) 1993-09-15
NO883007D0 (no) 1988-07-05
SK279037B6 (sk) 1998-05-06
ATE91127T1 (de) 1993-07-15
NZ225163A (en) 1991-04-26
NO170727B (no) 1992-08-17
PT87913B (pt) 1995-03-01
HUT50152A (en) 1989-12-28
AR245710A1 (es) 1994-02-28
PT87913A (pt) 1989-06-30
MX12168A (es) 1993-10-01
EP0298452A3 (en) 1989-04-05
DK370988A (da) 1989-01-07
MX174083B (es) 1994-04-20
IL86923A (en) 1994-02-27

Similar Documents

Publication Publication Date Title
MC1953A1 (fr) Derives de la benzopyrane
MC1992A1 (fr) Derives de fluorocytidine
TR26815A (tr) Azolilmetil-sikropil türevleri
DE3856154D1 (de) Adenosin-Derivate
MC1879A1 (fr) Derives de la pyridazodiazepine
TR24894A (tr) N-FENILPIRAZOL TüREVLERI
DK507188D0 (da) Cholecalciferolderivater
FR2639044B1 (fr) Derives de la butynylamine
DK378088D0 (da) Alkenderivater
DK223588A (da) Benzazepinderivater
MC1916A1 (fr) Derives de propiolophenone
DK110088A (da) Chromonderivater
MC1984A1 (fr) Derives de la purine
BR8905292A (pt) Derivados de piranobenzoxadiazois
MC1934A1 (fr) Derives de pyrimidine
DK453788A (da) Rifamycinderivater
DK271088A (da) Tienopyridinderivater
MC2108A1 (fr) Derives de quinoleine
DK695788A (da) Naphtalenderivater
FR2595704B1 (fr) Derives de la proline
DK71488A (da) Dipenylethylen-derivater
DK733688D0 (da) Dioxazocinderivater
DK46288A (da) Pilocarpinderivater
KR890003365U (ko) 패용 표찰
FR2629901B1 (fr) Antiretour de fumee

Legal Events

Date Code Title Description
YP Annual fee paid